Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency
about
Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionThe Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNACompounds that target novel cellular components involved in HIV-1 transcriptionLive cell imaging of single genomic loci with quantum dot-labeled TALEs.Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication.Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitorsDirect and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latencyIron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNAT cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.HIV and malnutrition: effects on immune system.Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individualsInvolvement of a spliced and defective human foamy virus in the establishment of chronic infection.Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivoNuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infectionInduction of HIV-1 latency and reactivation in primary memory CD4+ T cellsA point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.HIV integration sites in latently infected cell lines: evidence of ongoing replication.Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoterType I interferon responses are impaired in latently HIV infected cells.Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicingSelective amplification of RNA utilizing the nucleotide analog dITP and Thermus thermophilus DNA polymeraseReactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment.eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
P2860
Q24559797-B5FEBF6E-9E2C-4EFC-8210-6CF8082DEE49Q24647541-FDEA949B-5016-473D-B6A7-D8616AB87C64Q28378815-AAB4B2DF-B6EB-4776-B595-F3A1EC44C114Q30848166-95838407-5C7B-42A0-A384-B25D94E793D6Q33589167-71EBAB45-FE60-45AB-9BD9-A2AE1BA6FE7EQ33640317-016E158B-2A4E-401A-9FF6-C28C19E35D45Q33728042-EDE520B9-2720-458B-A545-C17AB06B9C8AQ33784862-6680FBE3-A20A-415D-93AD-E68E98AD25C5Q33785931-AB7B9DD5-AAA5-4CBF-9CEA-20B487193B36Q33835882-2DFCC63E-E0C0-472D-85E5-863BB7EFA9C8Q34362915-ACE66CF0-E77D-4208-8E55-8A7B027CB366Q34458484-A6972A2F-4E3E-4E72-96F0-BBAD3302C5A1Q34465108-BE4CB149-265F-4E7F-A475-CA22A0DE6DEEQ34469824-5A016E58-B11E-44D1-8C9A-3F0FE956E3EAQ34662450-451BE4EE-F6CF-4A8B-80B1-2865BDD17A16Q35661554-1DA1829D-FECC-4360-BFDD-84EFA5053359Q35828687-E9E650C5-614B-4993-A675-83DB2024772AQ35837198-E373E9D4-C95D-47CC-9125-13177F31E8FAQ35845440-094203B3-2425-49DB-B7A2-33679546503DQ35871860-190580CB-0EE1-4C62-B007-BD570B02EB12Q35874904-DCA81733-4480-4971-B3E2-DD4B7A346FE3Q36063873-392CD831-BEB4-4C44-A5F2-04457041EBE9Q36576849-5A4E4F42-6BD2-4243-BD63-B835209C2CE5Q37039142-266F0114-155F-449D-AE1D-4A4739771C1FQ37518835-B07E722F-871E-47C1-AD1E-C15DF6C2B148Q37586737-30B97947-EE2B-4AB5-8EB2-220B2759327CQ37596980-6EBB522D-00B2-44E0-A89C-596F0D49835EQ38747126-280E8C0B-F60C-48A0-AAFA-AD6D091B6FB9Q39683417-D5A2172B-84BB-483C-884F-6B14262C0FE7Q39718476-88D660DF-39B6-4F63-956A-D3910FD2DA72Q39826186-89D1975A-8156-4F6F-AF3E-D905242E6FBDQ47564080-3B787410-E621-42CB-B66C-83C0C60DD947
P2860
Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Human immunodeficiency virus t ...... multiple mechanisms of latency
@ast
Human immunodeficiency virus t ...... multiple mechanisms of latency
@en
type
label
Human immunodeficiency virus t ...... multiple mechanisms of latency
@ast
Human immunodeficiency virus t ...... multiple mechanisms of latency
@en
prefLabel
Human immunodeficiency virus t ...... multiple mechanisms of latency
@ast
Human immunodeficiency virus t ...... multiple mechanisms of latency
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... multiple mechanisms of latency
@en
P2093
P2860
P304
P407
P577
1994-04-01T00:00:00Z